{"schema_version":"secwatch.filing_event.v1","accession":"0001156039-25-000007","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2025-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.044393+00:00","generated_at":"2026-05-27T13:19:53.359741+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Elevance Health Q4 2024 adjusted EPS $3.84, FY 2025 guidance $34.15-$34.85; dividend raised 5% to $1.71","bullets":["Q4 operating revenue $45.0B (+6% YoY); FY revenue $175.2B (+3%).","Q4 GAAP EPS $1.81; adjusted EPS $3.84. FY GAAP EPS $25.68; adjusted EPS $33.04.","Health Benefits Q4 operating margin 0.6% (down from 2.1% YoY) on higher Medicaid cost trend.","Carelon Q4 adjusted operating margin 5.3% (up from 4.8% YoY); FY adjusted margin 5.8%.","FY 2025 adjusted EPS guidance $34.15-$34.85; dividend raised 5% to $1.71, payable 3/25/25."],"urls":{"canonical":"https://secwatch.observer/filing/0001156039-25-000007","json":"https://secwatch.observer/filing/0001156039-25-000007.json","markdown":"https://secwatch.observer/filing/0001156039-25-000007.md","text":"https://secwatch.observer/filing/0001156039-25-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000007/0001156039-25-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000007/elv-20250123.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T13:19:53.359741+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}